AR080294A1 - Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia - Google Patents

Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia

Info

Publication number
AR080294A1
AR080294A1 ARP110100555A ARP110100555A AR080294A1 AR 080294 A1 AR080294 A1 AR 080294A1 AR P110100555 A ARP110100555 A AR P110100555A AR P110100555 A ARP110100555 A AR P110100555A AR 080294 A1 AR080294 A1 AR 080294A1
Authority
AR
Argentina
Prior art keywords
solubility
administration
magnolia
improve
active compounds
Prior art date
Application number
ARP110100555A
Other languages
English (en)
Inventor
Subramanyam Ravi
Fei Lin
Guofeng Xu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR080294A1 publication Critical patent/AR080294A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Métodos para el mejoramiento de la solubilidad y administracion de uno o más de los ingredientes activos hallados en el extracto de magnolia o uno de sus análogos sintéticos, en una composicion de uso oral. Reivindicacion 1: Una composicion de uso oral caracterizada porque incluye entre 0,05 y 10% en peso de propilenglicol; entre 0,05 y 5% en peso de al menos uno o más de los ingredientes activos hallados en el extracto de magnolia o uno de sus análogos sintéticos, donde al menos uno de los uno o más ingredientes activos es seleccionado a partir del grupo constituido por extracto de magnolia, magnolol, honokiol, tetrahidromagnolol, tetrahidrohonokiol (propilhonokiol), 5,5'-di-n-butil-bifenil-2,2'-diol y una combinacion de dos o más de ellos; y un vehículo oralmente aceptable.
ARP110100555A 2010-02-24 2011-02-24 Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia AR080294A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30766410P 2010-02-24 2010-02-24

Publications (1)

Publication Number Publication Date
AR080294A1 true AR080294A1 (es) 2012-03-28

Family

ID=43768879

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100555A AR080294A1 (es) 2010-02-24 2011-02-24 Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia

Country Status (15)

Country Link
US (1) US9801940B2 (es)
EP (1) EP2523676B1 (es)
JP (1) JP5665888B2 (es)
CN (1) CN102762219B (es)
AR (1) AR080294A1 (es)
AU (1) AU2011220789B2 (es)
BR (1) BR112012019997A2 (es)
CA (1) CA2788423A1 (es)
CO (1) CO6592076A2 (es)
MX (1) MX2012009139A (es)
RU (2) RU2552322C2 (es)
SG (1) SG183117A1 (es)
TW (1) TWI422382B (es)
WO (1) WO2011106492A1 (es)
ZA (1) ZA201206068B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI459957B (zh) * 2010-02-24 2014-11-11 Colgate Palmolive Co 口腔保健組成物
SG190880A1 (en) 2010-12-21 2013-07-31 Colgate Palmolive Co Halogenated biphenols as antibacterial agents
CN103764106B (zh) 2011-09-08 2018-10-19 高露洁-棕榄公司 基于3,3’-二烷基-1,1’-联苯-2,2’-二酚或3,3’-二烯基-1,1’-联苯-2,2’-二酚的口腔和皮肤护理组合物
JP2015500233A (ja) 2011-12-02 2015-01-05 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ オーラルケア組成物
RU2014126871A (ru) * 2011-12-02 2016-02-10 Колгейт-Палмолив Компани Композиции для гигиены полости рта
EP2790645B1 (en) 2011-12-15 2016-10-05 Colgate-Palmolive Company Solubilized magnolol analogs
CA2857648A1 (en) * 2011-12-15 2013-06-20 Colgate-Palmolive Company Oral care or cleanser composition comprising solubilized magnolol analogs and ppg-1- peg-9 lauryl glycol ether
CA2858032A1 (en) * 2011-12-15 2013-06-20 Colgate-Palmolive Company Solubilized magnolol analogs
US9000231B2 (en) 2011-12-20 2015-04-07 Colgate-Palmolive Company Processes for making magnolol and derivatives thereof
CN104066702B (zh) 2011-12-20 2016-01-20 高露洁-棕榄公司 厚朴酚类似物的制备方法
US9795548B2 (en) * 2012-03-02 2017-10-24 Colgate-Palmolive Company Oral care compositions
WO2014115156A1 (en) 2013-01-23 2014-07-31 Colgate-Palmolive Company Processes for making magnolol derivatives
WO2014131191A1 (en) * 2013-03-01 2014-09-04 Johnson & Johnson Consumer Companies, Inc. A composition containing honokiol and/or magnolol and uses thereof
RU2744578C2 (ru) * 2015-07-14 2021-03-11 Вм. Ригли Джр. Компани Экстракт коры магнолии в качестве гидрофобного лиганда для преимущественного удаления грамотрицательных бактерий из ротовой полости

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0176015B1 (ko) 1996-03-26 1999-03-20 서치영 치주질환 예방 및 치료제 조성물
AU2000246679A1 (en) * 2000-04-27 2001-11-12 The Procter And Gamble Company Oral compositions comprising polyphenol herbal extracts
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US6544409B2 (en) 2001-05-16 2003-04-08 Petroleo Brasileiro S.A. - Petrobras Process for the catalytic oxidation of sulfur, nitrogen and unsaturated compounds from hydrocarbon streams
CN1147286C (zh) 2001-07-18 2004-04-28 广州美晨股份有限公司 一种中药牙膏
US7347985B2 (en) * 2002-06-25 2008-03-25 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract
US7632525B2 (en) 2002-06-25 2009-12-15 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
EP1515690A4 (en) * 2002-06-25 2006-05-24 Wrigley W M Jun Co REFRACTORY AND MOUTH CLEANSING PRODUCT WITH EXTRACT FROM THE MAGNOLINE CLEANER
US20060127329A1 (en) * 2004-12-10 2006-06-15 Colgate-Palmolive Company Tartar control oral care composition containing extract of magnolia
US8900644B2 (en) * 2004-12-22 2014-12-02 Colgate-Palmolive Company Oral care compositions containing compounds from magnolia and hops extracts
US8071077B2 (en) * 2004-12-29 2011-12-06 Colgate-Palmolive Company Oral compositions containing biphenol antibacterial compounds
US20060140885A1 (en) * 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
CN101132806A (zh) * 2004-12-29 2008-02-27 高露洁-棕榄公司 使用木兰提取物减少口腔组织炎症的方法
WO2006129898A1 (en) 2005-05-30 2006-12-07 Korea Institute Of Oriental Medicine A mass separation method of magnolol from magnoliae cortex ormagnoliae radix
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
RU2440821C2 (ru) 2007-10-01 2012-01-27 Колгейт-Палмолив Компани Композиции для ухода за полостью рта, содержащие растительные экстракты

Also Published As

Publication number Publication date
RU2552322C2 (ru) 2015-06-10
TWI422382B (zh) 2014-01-11
JP2013520517A (ja) 2013-06-06
EP2523676B1 (en) 2016-04-20
US20120294812A1 (en) 2012-11-22
JP5665888B2 (ja) 2015-02-04
US9801940B2 (en) 2017-10-31
RU2015114797A (ru) 2015-09-20
ZA201206068B (en) 2015-04-29
WO2011106492A1 (en) 2011-09-01
AU2011220789B2 (en) 2013-07-18
RU2012140474A (ru) 2014-03-27
EP2523676A1 (en) 2012-11-21
TW201204376A (en) 2012-02-01
CO6592076A2 (es) 2013-01-02
AU2011220789A1 (en) 2012-08-23
SG183117A1 (en) 2012-09-27
CA2788423A1 (en) 2011-09-01
CN102762219B (zh) 2016-05-04
MX2012009139A (es) 2012-09-21
CN102762219A (zh) 2012-10-31
BR112012019997A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
AR080294A1 (es) Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia
AR080295A1 (es) Composiciones para el cuidado bucal y metodos de tratamiento
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
GT201400136A (es) Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos
CU20140068A7 (es) Triazolopiridinas sustituidas
AR082686A1 (es) Adyuvantes de vacuna que direccionan a los adyuvantes de anticuerpos directamente hacia las celulas presentadoras de antigenos
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
CU20120171A7 (es) Triazolopiridinas sustituidas
CO6480948A2 (es) Composición farmacéutica para la anticoncepción de emergencia
BR112016010080A8 (pt) compostos de pirazolopirimidina, composição farmacêutica e seu uso
ES2969144T3 (es) Formulaciones orales de análogos de citidina y métodos de uso de los mismos
AR085042A1 (es) Composiciones de cuidado oral con extracto de magnolia
ECSP13013011A (es) Triazolopiridinas
CL2017000293A1 (es) Compuestos derivados de benzofurano sustituido en posición 6 por un radical que contiene boro; composición farmacéutica que los comprende; uso en el tratamiento de la hepatitis c (divisional del cl 393-2014)
BR112014002594A2 (pt) uso de diésteres de isossorbida como espessantes
AR083769A1 (es) Formulaciones orales que comprenden polietilenglicol
CO2017007057A2 (es) Vacuna contra la fiebre aftosa
BR112014002570A2 (pt) uso de monoésteres de isossorbida como espessantes
ECSP10010078A (es) Co-cristales de pirimetanilo y ditianona
CR11755A (es) Dronedarona para la prevencion de la cardioversion
BR112015014180A8 (pt) composições de gel
CL2011003355A1 (es) Compuestos derivados de alcoxi-carbonil-amino-alquinil-adenosina ; composición farmacéutica que los comprende; uso del compuesto en la preparación de un medicamento útil para tratar enfermedades autoinmunes, inflamatorias, alérgicas, infecciosas entre otras.
CL2014000754A1 (es) Compuestos aldehidos cicloalcanicos; procedimiento de preparacion; composicion que los comprende ademas de al menos otra sustancia odorante; su uso en composiciones de perfumeria, composiciones topicas cosmeticas o tambien productos de limpieza.
BR112015008772A2 (pt) composição oral sólida contendo corantes para uso em diagnóstico endoscópico
CO6290697A2 (es) Composicion farmaceutica que comprende un peptido derivado del transcrito regulado por ***a y anfetamina (cart) y un excipiente

Legal Events

Date Code Title Description
FB Suspension of granting procedure